Skip to main content
    A

    Alector Inc (ALEC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.56
    -0.01 (-0.39%)

    Market Cap: $382.61M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Alector Inc (ALEC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Alector (ALEC) has a market cap of $382.61M and an enterprise value of $307.14M. Revenue grew 151.23% over the last 12 months from the 12 months before. Its share count is up 9.03% from a year earlier.

    Total Valuation

    Enterprise value is 19.73% below the market cap, as cash exceeds debt.

    Market Cap$382.61M
    Enterprise Value$307.14M
    Latest price (Nov 17, 2026)$2.56

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.57% in the quarter ended Sep 30, 2026 and grew 7.10% a year over 2 years.

    Shares Outstanding111.86M
    Shares Change (YoY)+9.03%
    Shares Change (QoQ)+0.57%
    Share Count Growth (2Y CAGR)+7.10%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 2.5x.

    P/E Ratio7.3x
    P/S Ratio1.7x
    Forward P/S1.7x
    P/B Ratio2.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 4.4x EBITDA.

    EV / Earnings7.4x
    EV / Sales1.8x
    EV / EBITDA4.4x
    EV / EBIT7.4x

    Price Statistics

    The stock is up 106.45% over 52 weeks and trades 23.67% above its 50-day average.

    Beta (1Y)1.66
    52-Week Change+106.45%
    1-Month Change+31.28%
    3-Month Change+5.35%
    6-Month Change+21.33%
    5-Year Change-89.83%
    Total Return (1Y)+106.45%
    Total Return (3Y CAGR)-15.94%
    Total Return (5Y CAGR)-35.01%
    Return vs SPY (1Y)+90.02%
    Max Drawdown (1Y)-48.61%
    Max Drawdown (3Y)-89.22%
    Sharpe Ratio (1Y)0.86
    Correlation with SPY (1Y)0.28
    50-Day Average$2.07
    200-Day Average$2.06
    52-Week Range$1.09 to $2.84
    RSI (14 Days)62.3
    Average Volume (20 Days)1.97M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.10x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio4.10x
    Quick Ratio4.10x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 35.53% and return on assets is 24.98% over the last 12 months.

    Return on Equity (ROE)35.53%
    Return on Assets (ROA)24.98%
    Return on Capital Employed (ROCE)32.04%
    ROA (5Y Average)-23.30%
    Asset Turnover0.69x

    Taxes

    Income tax took 0.86% of pretax income over the last 12 months.

    Income Tax (TTM)$358.00K
    Effective Tax Rate0.86%

    Scores

    ALEC has an Altman Z-Score of -1.38, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-1.38
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $173.47M over the last 12 months.

    Revenue$173.47M
    Revenue Growth (YoY)+151.23%
    Gross Profit$173.47M
    Operating Income$34.96M
    Pretax Income$41.77M
    Net Income$41.41M
    EBITDA$47.75M
    EBIT$41.77M
    Reported EPS (TTM)$0.35

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 70.32% of the $165.78M in total assets.

    Cash and Equivalents$75.47M
    Total Debt$0
    Net Cash$75.47M
    Net Cash Per Share$0.67
    Working Capital$109.93M
    Shareholder Equity$116.57M
    Book Value Per Share$1.04
    Total Assets$165.78M
    Total Liabilities$49.21M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$149.88M
    FCF Per Share-$1.34
    Depreciation and Amortization$6.13M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 20.16%.

    Gross Margin100.00%
    Operating Margin20.16%
    Pretax Margin24.08%
    Net Margin23.87%
    EBITDA Margin27.52%
    EBIT Margin24.08%

    Growth

    Revenue fell 46.00% a year over 3 years.

    Revenue Growth (3Y CAGR)-46.00%
    Revenue Growth (5Y CAGR)-0.05%
    Book Value Per Share Growth (2Y CAGR)-56.90%
    Tangible Book Per Share Growth (2Y CAGR)-56.90%

    Revenue and profit by year

    Dividends and Yields

    ALEC does not pay a dividend.

    Earnings Yield13.70%
    Buyback Yield-1.88%
    Shareholder Yield-1.88%

    Peer Position

    Against 4 similar companies, ALEC has the lowest P/S.

    P/S Ratio1.7x vs 7.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)+151.23% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -8.91% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-8.91%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ALEC

    What is ALEC's market cap?

    Alector has a market cap of $382.61M. Its enterprise value, which adds debt and subtracts cash, is $307.14M.

    What is ALEC's P/E ratio?

    Alector has a trailing P/E ratio of 7.3x.

    How many shares of ALEC are outstanding?

    Alector has 111.86M shares outstanding. The count is up 9.03% from a year earlier.

    Does ALEC pay a dividend?

    No. Alector does not pay a dividend.

    How much debt does ALEC have?

    Alector has $0 of total debt and $75.47M of cash and equivalents, a net cash position of $75.47M.